Johnson & Johnson ($JNJ) announced yesterday that Ethicon has completed the acquisition of Auris Health for approximately $3.4 billion in cash as well as the divestiture of its Advanced Sterilization Products...
Allergan and Sonja Morgan are continuing her partnership with CoolSculpting to talk about "Bikini Denial" which is a feeling many women get around swimsuit swimsuit season as they are not prepared to hit the beach or pool until they get rid of their stubborn fat....
After recently gaining FDA clearance for their brain and knee applications, Zimmer Biomet today announced the 510(k) clearance the the ROSA ONE Spine System. This approval means that Zimmer Biomet is now the first company with 510(k) clearance for Brain, Spine and Knee applications within one platform....
The Department of Homeland Security (DHS) published a warning about Medtronic implantable defibrillators and the vulnerabilities in the devices, which could potentially allow them to be hacked by nearby attackers....
With their stock down over 94% in the last year, Nevro finally pulled the trigger and made a change at the top with Rami Elghandour stepping down and being replaced with D. Keith Grossman who will be appointed as Nevro's CEO and a member of the Board of Directors....
Boston Scientific was down more than 5% on positive Edwards' Sapien 3 data presented on Sunday, March, 17, at the American College of Cardiology meeting. Edwards' stock was up almost 7% at the time of writing....
According to the Department of Justice, Covidien, now part of Medtronic, has agreed to pay approximately $20 million to resolve False Claim Act allegations....
Stryker ($SYK) announced they are acquiring OrthoSpace for up to $220 million. The all cash deal includes an upfront payment of $110 million and future milestone payments of up to an additional $110 million....
Originally approved in 2013 for patients with mitral valve abnormalities who are not suitable for mitral valve surgery, Abbott's MitraClip was given the FDA ok for expanded use today....
Earlier this week, BD (Becton, Dickinson and Company) announced the FDA premarket approval for the Venovo venous stent, which is the first stent indicated to treat iliofemoral venous occlusive disease....